Roche Launches Test Assessing Drug Metabolism; Psychiatrists Targeted
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics is targeting psychiatrists with a medical education program as part of the launch of its AmpliChip CYP450 genomic test, which assesses how patients metabolize certain drugs
You may also be interested in...
Affymetrix Partners To Push Gene Chips Into Diagnostics Space
Affymetrix, the inventors of genetic microarray technology used to explore the human genome in the 1990s, is leading the charge to apply the powerful research tool to human diagnostics
Affymetrix Partners To Push Gene Chips Into Diagnostics Space
Affymetrix, the inventors of genetic microarray technology used to explore the human genome in the 1990s, is leading the charge to apply the powerful research tool to human diagnostics
Unfinished Business: Demonstrating Value In Pharmacogenomic Testing
Pharmacogenomic testing and personalized medicine are clearly the wave of the future, but establishing their value to society will be key for their successful adoption, economist Kathryn Phillips, PhD, University of California-San Francisco, maintained at an April 4 symposium sponsored by Johns Hopkins University's Genetics and Public Policy Center